Bio-Rad launches external quality assurance services specialty immunoassay program

Bio-Rad Laboratories has launched its External Quality Assurance Services (EQAS) Specialty Immunoassay (SPIA) Program.

The new EQAS SPIA program is a liquid, independent, and confidential external assessment program that consolidates 13 complex and highly tested specialty immunoassay analytes, including procalcitonin, active vitamin B12, interleukin-6, and fructosamine, at both normal and abnormal levels.

This expanded menu enhances the clinical utility across different disease areas such as sepsis, anemia, diabetes, and thyroid disorders, while the analyte consolidation reduces costs by eliminating the need for participation in multiple EQA programs.

EQAS SPIA offers a user-friendly online platform for data access and reporting, combined with full ISO/IEC 17043 accreditation. This ensures labs worldwide to meet proficiency testing regulatory requirements while providing lab professionals with the tools to confidently assess performance and identify areas of improvement.

Bio-Rad’s EQAS SPIA is designed to streamline proficiency testing with seamless data submission and easy-to-read reports while the ready- to-use liquid format minimizes handling errors to simplify EQA testing workflows.

For ordering information or to learn more, click here: https://bit.ly/47Sf1LI.